Everence Capital Management
IONS icon

Everence Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Everence Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$278K Hold
6,232
– – 0.01% 644
2026
Q2 		$494K Hold
6,232
– – 0.03% 421
2026
Q1 		$468K Sell
6,232
-538
-8% -$42.5K 0.03% 398
2025
Q4 		$536K Hold
6,770
– – 0.03% 372
2025
Q3 		$443K Hold
6,770
– – 0.03% 433
2025
Q2 		$267K Hold
6,770
– – 0.02% 628
2025
Q1 		$204K Hold
6,770
– – 0.01% 737
2024
Q4 		$237K Buy
+6,770
New +$253K 0.02% 696

Other funds holding IONS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

Everence Capital Management's IONS Position: Q3 2026 in Review

Everence Capital Management held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 6,232 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #644.

Everence Capital Management first reported a position in IONS in Q4 2024 and has held it in 8 quarters since. The position peaked at $536K in Q4 2025. 193 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Everence Capital Management held 6,232 shares of Ionis Pharmaceuticals worth $278K as of Q3 2026.
  • Everence Capital Management left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up 0.01% of Everence Capital Management's portfolio in Q3 2026, its #644 holding.
  • Everence Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Everence Capital Management's Ionis Pharmaceuticals position peaked at $536K in Q4 2025.
  • 193 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.